Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Hiratsuka
FRI0075 Rheumatoid Arthritis Patients Receiving Glucocorticoid Exhibits Significant Bone Quality Abnormalities, Leading to Severe Bone Fragility Regardless of Bisphosphonate Treatment
Related publications
Mechanisms of Bone Fragility in a Mouse Model of Glucocorticoid-Treated Rheumatoid Arthritis: Implications for Insufficiency Fracture Risk
Arthritis & Rheumatism
Significant Improvement of Bone Mineral Density and Bone Turnover Markers by Denosumab Therapy in Bisphosphonate-Unresponsive Patients
Osteoporosis International
Medicine
Endocrinology
Metabolism
Diabetes
Serum Serotonin Levels and Bone in Rheumatoid Arthritis Patients
Rheumatology International
Rheumatology
Allergy
Immunology
Bone Mineral Density in Patients With Early- Onset Rheumatoid Arthritis
Medical Journal of Bakirkoy
Medicine
Flowcytometric Analysis of Bone Marrow Cells From Patients With Rheumatoid Arthritis.
Ensho
Does Anti-TNF Therapy Cause a Less Significant Fall in Bone Mineral Density in Patients With Rheumatoid Arthritis?
The Internet Journal of Rheumatology
Low Doses Glucocorticoid Effect on Joint Destruction and Mineral Bone Density in Early Rheumatoid Arthritis
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
MSX-1 Is Suppressed in Bisphosphonate-Exposed Jaw Bone Analysis of Bone Turnover-Related Cell Signalling After Bisphosphonate Treatment
Oral Diseases
Otorhinolaryngology
Dentistry
Bone and TNF in Rheumatoid Arthritis: Clinical Implications
RMD Open
Rheumatology
Allergy
Immunology
